Body fat in nonobese women with prolactinoma treated with dopamine agonists

Clinical Endocrinology

Volumn 67, Issue 6, 2007, Pages 845-852

  Naliato, Erika C O ^a,b   Violante, Alice H D ^b   Caldas, Dayse ^b   Filho, Adilson Lamounier ^b   Loureiro, Christiane R ^b   Fontes, Rosita ^b   Schrank, Yolanda ^b   Souza, Rodrigo G ^b   Costa, Patricia L M ^b   Colao, Annamaria ^c  

^a Clementino Fraga Filho University Hospital ^*  (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; ESTRADIOL; PROLACTIN;

ADULT; ARTICLE; BLOOD ANALYSIS; BODY FAT; BODY MASS; CLINICAL EVALUATION; CONTROLLED STUDY; DEMOGRAPHY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROLACTINOMA;

ABSORPTIOMETRY, PHOTON; ADIPOSE TISSUE; ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; DOPAMINE AGONISTS; FEMALE; FOLLICLE STIMULATING HORMONE; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LUTEINIZING HORMONE; MIDDLE AGED; OBESITY; PROLACTIN; PROLACTINOMA; SEX HORMONE-BINDING GLOBULIN; THYROTROPIN; YOUNG ADULT;

EID: 36248930911     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.02973.x     Document Type: Article

References (30)

1. Gillam, M.P., Molitch, M.E., Lombardi, G. Colao, A. (2006) Advances in the treatment of prolactinomas. Endocrine Reviews, 27, 485 534.
2. Biller, B.M., Baum, H.B., Rosenthal, D.I., Saxe, V.C., Charpie, P.M. Klibanski, A. (1992) Progressive trabecular osteopenia in women with hyperprolactinemia amenorrhea. Journal of Clinical Endocrinology and Metabolism, 75, 692 697.
3. Naliato, E.C.O., Farias, M.L.F., Braucks, G.R., Costa, F.S.R., Zylberberg, D. Violante, A.H.D. (2005) Prevalence of osteopenia in men with prolactinoma. Journal of Endocrinological Investigation, 28, 12 17.
4. Colao, A., Di Somma, C., Loche, S., Di Sarno, A., Klain, M., Pivonello, R., Pietrosante, M., Salvatore, M. Lombardi, G. (2000) Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization. Clinical Endocrinology, 52, 319 327.
5. Sorenson, R.L., Brelje, T.C. Roth, C. (1993) Effects of steroid and lactogenic hormones on islets of Langerhans: a new hypothesis for the role of pregnancy steroids in the adaptation of islets to pregnancy. Endocrinology, 133, 2227 2234.
6. Greenman, Y., Tordjman, K. Stern, N. (1998) Increased body weight associated with prolactin secreting pituitary adenomas: weight loss with normalization of prolactin levels. Clinical Endocrinology, 48, 547 553.
7. Pijl, H. (2003) Reduced dopaminergic tone in hypothalamic neural circuits: expression of a 'thrifty' genotype underlying the metabolic syndrome? European Journal of Pharmacology, 480, 125 131.
8. Watanobe, H., Suda, T., Wikberg, J.E. Schïoth, H.B. (1999) Evidence that physiological levels of circulating leptin exert stimulatory effect on luteinizing hormone and prolactin surges in rats. Biochemical and Biophysical Research Communications, 263, 162 165.
9. Kok, P., Roelfsema, F., Frölich, M., Meinders, A.E. Pijl, H. (2004) Prolactin release is enhanced in proportion to excess visceral fat in obese women. Journal of Clinical Endocrinology and Metabolism, 89, 4445 4449.
10. Gualillo, O., Lago, F., García, M., Menéndez, C., Señarís, R. Diéguez, C. (1999) Prolactin stimulates leptin secretion by rat white adipose tissue. Endocrinology, 140, 5149 5153.
11. Comings, D.E., Flanagan, S.D., Dietz, G., Muhleman, D., Knell, E. Gysin, R. (1993) The dopamine D2 receptor (DRD2) as a major gene in obesity and height. Biochemical Medicine and Metabolic Biology, 50, 176 185.
12. Carruba, M.O., Ricciardi, S., Müller, E.E. Mantegazza, P. (1980) Anoretic effect of lisuride and other ergot derivatives in the rat. European Journal of Pharmacology, 64, 133 141.
13. Cincotta, A.H. Meier, A.H. (1995) Bromocriptine inhibits in vivo free fatty acid oxidation and hepatic glucose output in seasonally obese hamsters (Mesocricetus auratus). Metabolism, 44, 1349 1355.
14. Cincotta, A.H. Meier, A.H. (1985) Prolactin permits the expression of a circadian variation in lipogenic responsiveness to insulin in hepatocytes of the golden hamster (Mesocricetus auratus). Journal of Endocrinology, 106, 173 176.
15. Carey, R.M., Van Loon, G.R., Baines, A.D. Kaiser, D.L. (1983) Suppression of basal and stimulated noradrenergic activities by the dopamine agonist bromocriptine in man. Journal of Clinical Endocrinology and Metabolism, 56, 595 602.
16. Cincotta, A.H. Meier, A.H. (1996) Bromocriptine (ergoset) reduces body weight and improves glucose tolerance in obese subjects. Diabetes Care, 19, 667 670.
17. Mizutani, T., Nishikawa, Y., Adachi, H., Enomoto, T., Ikegami, H., Kurachi, H., Nomura, T. Miyake, A. (1994) Identification of estrogen receptor in human adipose tissue and adipocytes. Journal of Clinical Endocrinology and Metabolism, 78, 950 954.
18. Dieudonné, M.N., Pecquery, R., Boumediene, A., Leneveu, M.C. Giudicelli, Y. (1998) Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids. American Journal of Physiology, 274, C1645 C1652.
19. Gambacciani, M., Ciaponi, M., Cappagli, B., Piaggesi, L., De Simone, L., Orlandi, R. Genazzani, A. (1997) Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women. Journal of Clinical Endocrinology and Metabolism, 82, 414 417.
20. Kreisberg, R.A. Oberman, A. (2002) Lipids and atherosclerosis: lessons learned from randomized controlled trials of lipid lowering and other relevant studies. Journal of Clinical Endocrinology and Metabolism, 87, 423 437.
21. Bray, G.A. (2004) Medical consequences of obesity. Journal of Clinical Endocrinology and Metabolism, 89, 2583 2589.
22. Grundy, S.M. (2004) Obesity, metabolic syndrome, and cardiovascular disease. Journal of Clinical Endocrinology and Metabolism, 89, 2595 2600.
23. Götherström, G., Svensson, J., Koranyi, J., Alpsten, M., Bosaeus, I., Bengtsson, B.-A. Johannsson, G. (2001) A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices. Journal of Clinical Endocrinology and Metabolism, 86, 4657 4665.
24. Raji, A., Gerhard-Herman, M.D., Warren, M., Raptopoulos, V., Mantzoros, C.S. Simonson, D. (2004) Insulin resistance and vascular dysfunction in non-diabetic asian indians. Journal of Clinical Endocrinology and Metabolism, 89, 3965 3972.
25. Abate, N., Haffner, S.M., Garg, A., Peshock, R.M. Grundy, S.M. (2002) Sex steroid hormones, upper body obesity, and insulin resistance. Journal of Clinical Endocrinology and Metabolism, 87, 4522 4527.
26. Ling, C., Svensson, L., Odén, B., Weijdegard, B., Edén, B. Billig, H. (2003) Identification of functional prolactin (PRL) receptor gene expression: PRL inhibits lipoprotein lipase activity in human white adipose tissue. Journal of Clinical Endocrinology and Metabolism, 88, 1804 1808.
27. Colao, A., Di Sarno, A., Cappabianca, P., Briganti, F., Pivonello, R., Di Somma, C., Faggiano, A., Biondi, B. Lombardi, G. (2003) Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia. European Journal of Endocrinology, 148, 325 331.
28. Doknic, M., Pekic, S., Zarkovic, M., Medic-Stojanoska, M., Dieguez, C., Casanueva, F. Popovic, V. (2002) Dopaminergic tone and obesity: an insight from prolactinomas treated with bromocriptine. European Journal of Endocrinology, 147, 77 84.
29. Kamath, V., Jones, C.N., Yip, J.C., Varasteh, B., Cincotta, A.H., Reaven, G.M. Chen, Y.I. (1997) Effects of a Quick-release form of bromocriptine (Ergoset) on fasting and postprandial plasma glucose, insulin, lipid, and lipoprotein concentrations in obese nondiabetic hyperinsulinemic women. Diabetes Care, 20, 1697 1701.
30. Meier, A.H., Cincotta, A.H. Lovell, W.C. (1992) Timed bromocriptine administration reduces body fat stores in obese subjects and hyperglycemia in type II diabetics. Experientia, 48, 248 253.